Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome☆
To access this article, please choose from the options below
☆ C.T. and F.T. have received research grants from Novartis and Bristol-Myers Squibb. The other authors who have taken part in this study declared that they do not have anything to disclose with respect to this manuscript.
PII: S0168-8278(09)00374-2
doi:10.1016/j.jhep.2009.04.022
© 2009 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
